StockData
10x Genomics, Inc. logo

10x Genomics, Inc. (TXG) stock

TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30111% above fair value
$57.07+0.77 (+1.37%)

Close on Nov 18, 2026Market cap $7.44BP/E –Yield –

10x Genomics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

10x Genomics's revenue for the twelve months ending Sep 30, 2026 was $618.58M, down 3.6% year over year. For fiscal 2025 it was $642.82M, up 5.2% from the year before. The highest annual figure on record is $642.82M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$642.82M+5.2%
FY2024Dec 31, 2024$610.79M-1.3%
FY2023Dec 31, 2023$618.73M+19.8%
FY2022Dec 31, 2022$516.41M+5.3%
FY2021Dec 31, 2021$490.49M+64.1%
FY2020Dec 31, 2020$298.85M+21.5%
FY2019Dec 31, 2019$245.89M+68.1%
FY2018Dec 31, 2018$146.31M+105.8%
FY2017Dec 31, 2017$71.09M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$150.67M+1.1%
Q2 FY2026Jun 30, 2026$151.04M-12.6%
Q1 FY2026Mar 31, 2026$150.84M-2.6%
Q4 FY2025Dec 31, 2025$166.03M+0.6%
Q3 FY2025Sep 30, 2025$149.00M-1.7%
Q2 FY2025Jun 30, 2025$172.91M+12.9%
Q1 FY2025Mar 31, 2025$154.88M+9.8%
Q4 FY2024Dec 31, 2024$165.02M-10.3%
Q3 FY2024Sep 30, 2024$151.65M-1.3%
Q2 FY2024Jun 30, 2024$153.10M+4.3%
Q1 FY2024Mar 31, 2024$141.01M+5.0%
Q4 FY2023Dec 31, 2023$183.98M+17.8%
Q3 FY2023Sep 30, 2023$153.64M+17.2%
Q2 FY2023Jun 30, 2023$146.82M+28.1%
Q1 FY2023Mar 31, 2023$134.29M+17.3%
Q4 FY2022Dec 31, 2022$156.23M+8.8%
Q3 FY2022Sep 30, 2022$131.07M+4.6%
Q2 FY2022Jun 30, 2022$114.61M-1.1%
Q1 FY2022Mar 31, 2022$114.50M+8.2%
Q4 FY2021Dec 31, 2021$143.53M+27.9%
Q3 FY2021Sep 30, 2021$125.30M+74.5%
Q2 FY2021Jun 30, 2021$115.84M+170.0%
Q1 FY2021Mar 31, 2021$105.82M+47.2%
Q4 FY2020Dec 31, 2020$112.22M+49.0%
Q3 FY2020Sep 30, 2020$71.82M+17.3%
Q2 FY2020Jun 30, 2020$42.91M-23.1%
Q1 FY2020Mar 31, 2020$71.91M+34.2%
Q4 FY2019Dec 31, 2019$75.29M+48.9%
Q3 FY2019Sep 30, 2019$61.21M+67.2%
Q2 FY2019Jun 30, 2019$55.82M+75.8%
Q1 FY2019Mar 31, 2019$53.58M+95.5%
Q4 FY2018Dec 31, 2018$50.55M–
Q3 FY2018Sep 30, 2018$36.61M–
Q2 FY2018Jun 30, 2018$31.74M–
Q1 FY2018Mar 31, 2018$27.41M–

More 10x Genomics figures

See a number that looks wrong?